Contactin-1: a promising progression biomarker and therapeutic target of carcinoma

Minerva Med. 2017 Apr;108(2):193-195. doi: 10.23736/S0026-4806.16.04683-8.

Authors

Ruijie Zhang¹, Lihua Xie¹, Chun Liu¹, Honghui Yang¹, Hua Lin¹, Qiang Zhang¹, Wenxiang Tang¹, Fuyun Ji², Shenghua Sun³

Affiliations

¹ Department of Respiratory Medicine, Third Xiangya Hospital, Central South University, Changsha, China.
² Institute of Human Respiratory Disease, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
³ Department of Respiratory Medicine, Third Xiangya Hospital, Central South University, Changsha, China - sunshenghua@csu.edu.on.

PMID: 28222587
DOI: 10.23736/S0026-4806.16.04683-8

No abstract available

Publication types

Letter
Review

MeSH terms

Biomarkers, Tumor / biosynthesis*
Carcinoma / diagnosis*
Carcinoma / drug therapy
Carcinoma / metabolism*
Contactin 1 / biosynthesis*
Disease Progression
Humans

Substances

Biomarkers, Tumor
CNTN1 protein, human
Contactin 1